Design, synthesis and molecular docking of thiazolidinedione based benzene sulphonamide derivatives containing pyrazole core as potential anti-diabetic agents
- 1 February 2018
- journal article
- research article
- Published by Elsevier BV in Bioorganic Chemistry
- Vol. 76, 98-112
- https://doi.org/10.1016/j.bioorg.2017.11.010
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Design and synthesis of 5-(substituted benzylidene)thiazolidine-2,4-dione derivatives as novel tyrosinase inhibitorsEuropean Journal of Medicinal Chemistry, 2012
- Synthesis and Biological Evaluation of Novel Thiazolidinedione Analogues as 15-Hydroxyprostaglandin Dehydrogenase InhibitorsJournal of Medicinal Chemistry, 2011
- Design, Synthesis, and Structure−Activity Relationship Studies of Novel 2,4,6-Trisubstituted-5-pyrimidinecarboxylic Acids as Peroxisome Proliferator-Activated Receptor γ (PPARγ) Partial Agonists with Comparable Antidiabetic Efficacy to RosiglitazoneJournal of Medicinal Chemistry, 2010
- Synthesis and anti-inflammatory activity of new arylidene-thiazolidine-2,4-diones as PPARγ ligandsBioorganic & Medicinal Chemistry, 2010
- Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonistsBioorganic & Medicinal Chemistry Letters, 2010
- Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in miceFood and Chemical Toxicology, 2010
- Synthesis, induced-fit docking investigations, and in vitro aldose reductase inhibitory activity of non-carboxylic acid containing 2,4-thiazolidinedione derivativesBioorganic & Medicinal Chemistry, 2008
- Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γJournal of Medicinal Chemistry, 2006
- Design and Synthesis of α-Aryloxyphenylacetic Acid Derivatives: A Novel Class of PPARα/γ Dual Agonists with Potent Antihyperglycemic and Lipid Modulating ActivityJournal of Medicinal Chemistry, 2005
- [[.omega.-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agentsJournal of Medicinal Chemistry, 1994